[CIS PIDD] [cis-pidd] Treatment question for Bare lymphocyte sydrome

Verbsky, James jverbsky at mcw.edu
Thu Nov 7 14:47:45 EST 2013


A question regarding treatment option for Bare lymphocyte syndrome



We have a 27yo diagnosed with BLS and transplanted with an 8/10 unrelated donor at 10 months of age. Did well and lost to follow up for about 20 years, then presented with esophageal and vaginal candidiasis, diffuse molluscum, and diffuse warts (2 years ago). Donor chimerism low, so a repeat BMT with the same donor was done(non T cell depleted). Tolerated well, with some improvement in warts and molluscum for about 6 months, now worsening again.



CD4 counts have ranged from 44-190, never above 200. No clear bump in response to second transplant.



The question is what to do now.



1) Donor lymphocyte infusion? Patient is 100% engrafted. She clearly needs some mature CD4 T cells, but at the risk of GVH



2) Any cytokine therapies? (IL2, IL7??)



3) Another transplant with new donor? (past donor is now 70 years old). Not likely to fix her, but perhaps she ill get a few more mature T cells in. Concerned about a third transplant that is unlikely to benefit her however.



Thanks for your thoughts





James Verbsky MD/PhD
Associate Professor of Pediatrics and Microbiology and Molecular Genetics
Medical College of Wisconsin
Milwaukee, WI 53226

________________________________
From: Markus Seidel [markus.seidel at medunigraz.at]
Sent: Wednesday, November 06, 2013 2:54 PM
To: CIS-PIDD
Subject: [cis-pidd] Evans Syndrome, iatrogenous CVID, granulomatous LIP

Dear Colleagues,
what would be your suggestions in the therapeutic dilemma in a young adult who
has been treated successfully with MMF for 5 years for Evans Syndrome, under that time had a CVID-like B-cell phenotype (<100/µL B cells, absence of csmB cells, IgG2 and IgA-def.), did not require Ig-substitution, no severe infections,
initially had severe pancytopenia, autoimmune hemolytic anemia,
who then developed granulomatous lymphocytic interstitial pneumonitis early this year (LIP, either as consequence of iatrogenous CVID or occupational dust exposure; no infectious agent identified)
and when IS was terminated, had recurrence of severe thrombocytopenia (<10.000/µL), neutropenia (600-900/µL), autoantibodies against neutrophils, platelets, pos. Coombs test, but recovered clinically from LIP, which now appears to be stable in Chest CT.
his mother suffered from granulomatosis with polyangiitis (GPA) – but no other than blood-cell tissue- or nuclear autoantibodies are detectable in the patient.

I fear that rituximab or other systemic IS would exacerbate his LIP, which has been stable for 4 months now under rapamycin (the latter did not improve his thrombocytopenia, though); the B cells recovered to >200/µL and >2% csmB cells after discontinuation of MMF, but are now lower again under rapamycin, DNT cells borderline increased 3-5% of CD3;
Romiplostim works short time (1-2 weeks), but doesn’t look like a very good long term option;
Splenectomy?, Danazole?, AZT?
...SCT?

Thanks for your comments or thoughts,
Sincerely,
Markus Seidel


Markus G. Seidel, M.D., Assoc.Prof.
Consultant| Dept.of Pediatric Hematology-Oncology | Univ.Clinics of Pediatric and Adolescent Medicine | Medical University Graz | Auenbruggerpl. 34/2 | A-8036 Graz | Austria | T. 0043 316 385 80215| F. 0043 316 385 13717 | Secr. 0043 316 385 13485 |
Coordinator of the Working Group for Pediatric Immunology of the Austrian Society of Pediatrics and Adolescent Medicine

________________________________
Attention:
This e-mail and any attachment is for authorised use by the intended recipient(s) only. It may contain proprietary, confidential and/or privileged information and should not be copied, disclosed, distributed, retained or used by any other party. If you are not an intended recipient please notify the sender immediately and delete this e-mail (including attachments and copies).




---

The CIS-PIDD listserv is supported by:

[http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg]
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org<https://cis.execinc.com/edibo/Signup> to join!

You are currently subscribed to cis-pidd as: jverbsky at mcw.edu<mailto:jverbsky at mcw.edu>.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183824783.922c198296ffdc754aad9421f3d685e1&n=T&l=cis-pidd&o=44083062

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=44088375
or send a blank email to leave-44088375-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org


More information about the PAGID mailing list